相关实验视频

Updated: Jul 29, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

"老"分子的新机会:通过非酶机制准PARP1活动

Pablo Iglesias¹, Marcos Seoane¹, Irene Golán-Cancela¹

¹Molecular Oncology Laboratory MOL, Departamento de Fisioloxía, Centro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS), Facultade de Medicina, Universidade de Santiago de Compostela and Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), 15782 Santiago de Compostela, Spain.

International journal of molecular sciences

|May 27, 2023

概括

聚ADP-ribose) 聚合酶1 (PARP1) 抑制剂在癌症中显示出治疗潜力. 新的研究表明,这些PARP抑制剂影响细胞循环调节,而不会影响PARP1的酶功能.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

聚基聚合酶1 (PARP1) 是DNA修复中的一个关键酶.
PARP1 抑制剂正在成为有前途的癌症治疗方法,特别是在同源重组 (HR) 缺乏和与 BRCA 相关的癌症中,利用合成致命性.
此外,PARP1还具有非DNA修复功能,包括在转录调节中的角色,作为联合激活剂或联合抑制剂.

研究的目的:

研究PARP1在细胞循环调节中的作用.
为了确定PARP抑制剂是否影响PARP1在细胞循环调节中的功能.
阐明 PARP 抑制剂影响细胞循环调节的机制.

主要方法:

在细胞模型中使用了PARP抑制剂.
评估PARP抑制剂对细胞循环调节蛋白的影响,特别关注转录因子E2F1.1.
在抑制剂的存在下评估了PARP1的酶活性.

主要成果:

发现PARP抑制剂干扰了PARP1在细胞循环调节中的作用.
这种干扰是独立于PARP1的酶活性发生的.
这项研究提供了证据表明,PARP抑制剂调节了PARP1作为E2F1.1的转录共激活剂的功能.

结论:

PARP 抑制剂具有双重作用机制,影响DNA 修复和细胞循环调节.
PARP1 的非酶功能是癌症治疗的关键标.
这些发现扩大了PARP抑制剂的治疗潜力,超出了它们在DNA修复中的既定作用.

关键词:

在 PARP 抑制剂.动物疾病模型动物疾病模型癌症癌症癌症癌症癌症这种新生体是瘤.聚 (ADP-ribose) 聚合酶-1 聚合酶-1 聚 (ADP-ribose) 聚合酶-1 聚合酶-1 聚合酶-1 聚 (ADP-ribose)

更多相关视频

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

Base Excision Repair

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...